Development and validation of a risk score in acute myocardial infarction-related cardiogenic shock.

ABSTRACT:

Aims

Mortality in patients with acute myocardial infarction-related cardiogenic shock (AMICS) is high, but a widely accepted tool for individual risk assessment is lacking. A reliable prediction model could assist in clinical decision-making, patient selection for clinical trials, and comparison of AMICS populations. Therefore, the aim of this study was to develop and externally validate a prediction model for 30-day mortality in AMICS patients.

Methods and results

This retrospective cohort study included patients from 2017 to 2021 (development cohort) and 2010-2017 (validation cohort). Patients with AMICS undergoing percutaneous coronary intervention in The Netherlands were identified using the Netherlands Heart Registration. International validation was performed in the Da

SUBMITTER: Peters EJ 

PROVIDER: S-EPMC12365599 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature